This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (24)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Drug Therapy, Other  • Surgical Interventions  • Cardiovascular/ Cardiothoracic Surgery  • Randomized Controlled Trial  • Arrhythmias  • Cardiovascular Intervention  • Revascularization  • Alert me on articles by topic

A Randomized Controlled Trial

Jari Halonen, MD; Pirjo Halonen, PhD; Otso Järvinen, MD, PhD; Panu Taskinen, MD; Tommi Auvinen, MD; Matti Tarkka, MD, PhD; Mikko Hippeläinen, MD, PhD; Tatu Juvonen, MD, PhD; Juha Hartikainen, MD, PhD; Tapio Hakala, MD, PhD

JAMA. 2007;297:1562-1567.

Context  Atrial fibrillation (AF) is the most common arrhythmia to occur after cardiac surgery. An exaggerated inflammatory response has been proposed to be one etiological factor.

Objective  To test whether intravenous corticosteroid administration after cardiac surgery prevents AF after cardiac surgery.

Design, Setting, and Patients  A double-blind, randomized multicenter trial (study enrollment August 2005–June 2006) in 3 university hospitals in Finland of 241 consecutive patients without prior AF or flutter and scheduled to undergo first on-pump coronary artery bypass graft (CABG) surgery, aortic valve replacement, or combined CABG surgery and aortic valve replacement.

Intervention  Patients were randomized to receive either 100-mg hydrocortisone or matching placebo as follows: the first dose in the evening of the operative day, then 1 dose every 8 hours during the next 3 days. In addition, all patients received oral metoprolol (50-150 mg/d) titrated to heart rate.

Main Outcome Measure  Occurrence of AF during the first 84 hours after cardiac surgery.

Results  The incidence of postoperative AF was significantly lower in the hydrocortisone group (36/120 [30%]) than in the placebo group (58/121 [48%]; adjusted hazard ratio, 0.54; 95% confidence interval, 0.35-0.83; P = .004; number needed to treat, 5.6). Compared with placebo, patients receiving hydrocortisone did not have higher rates of superficial or deep wound infections, or other major complications.

Conclusion  Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.

Trial Registration  clinicaltrials.gov Identifier: NCT00442494

Author Affiliations: Departments of Surgery and Internal Medicine, Kuopio University Hospital (Drs J. Halonen, Auvinen, Hippeläinen, and Hartikainen), and Computing Center of Kuopio University (Dr P. Halonen), Kuopio; Heart Center, Tampere University Hospital, Tampere (Drs Järvinen and Tarkka); and Department of Surgery, Oulu University Hospital (Drs Taskinen and Juvonen), and Department of Surgery, North Karelia Central Hospital (Dr Hakala), Joensuu, Finland.

RELATED LETTERS

Use of Corticosteroids to Prevent Atrial Fibrillation After Cardiac Surgery
Jaewon Oh, Ji-Hyung Chung, and Seok-Min Kang
JAMA. 2007;298(3):283.
EXTRACT | FULL TEXT  

Use of Corticosteroids to Prevent Atrial Fibrillation After Cardiac Surgery
John G. T. Augoustides
JAMA. 2007;298(3):283.
EXTRACT | FULL TEXT  

Use of Corticosteroids to Prevent Atrial Fibrillation After Cardiac Surgery—Reply
Jari Halonen, Juha Hartikainen, and Tapio Hakala
JAMA. 2007;298(3):283-284.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Reducing the Incidence of Atrial Fibrillation
John V. Conte
Arch Surg. 2007;142(9):821.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Year in Cardiovascular Surgery
Jones
J Am Coll Cardiol 2008;51:1707-1718.
FULL TEXT  

Update in Critical Care 2007
Fowler et al.
Am. J. Respir. Crit. Care Med. 2008;177:808-819.
FULL TEXT  

Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
Echahidi et al.
J Am Coll Cardiol 2008;51:793-801.
ABSTRACT | FULL TEXT  

Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery.
Kim et al.
J Am Coll Cardiol 2008;51:68-74.
ABSTRACT | FULL TEXT  

Post-operative atrial fibrillation and oxidative stress: a novel causal mechanism or another biochemical epiphenomenon?
Oral
J Am Coll Cardiol 2008;51:75-76.
FULL TEXT  

Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement.
Banach et al.
J. Thorac. Cardiovasc. Surg. 2007;134:1569-1576.
ABSTRACT | FULL TEXT  

Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data
Issac et al.
J Am Coll Cardiol 2007;50:2021-2028.
ABSTRACT | FULL TEXT  

Additional articles abstracted in ACP Journal Club
Evid. Based Med. 2007;12:158-158.
FULL TEXT  

Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
Vassallo and Trohman
JAMA 2007;298:1312-1322.
ABSTRACT | FULL TEXT  

Reducing the Incidence of Atrial Fibrillation
Conte
Arch Surg 2007;142:821-821.
FULL TEXT  

JournalScan
Lindsay
Heart 2007;93:1008-1010.
FULL TEXT  

Use of Corticosteroids to Prevent Atrial Fibrillation After Cardiac Surgery
Oh et al.
JAMA 2007;298:283-283.
FULL TEXT  

Use of Corticosteroids to Prevent Atrial Fibrillation After Cardiac Surgery
Augoustides
JAMA 2007;298:283-283.
FULL TEXT  

Can Steroids Prevent AFib After Cardiothoracic Surgery?
Journal Watch Cardiology 2007;2007:6-6.
FULL TEXT